Rheumatologists News and Research RSS Feed - Rheumatologists News and Research

CSRO survey reveals rheumatologists have concerns about biosimilars approval process

CSRO survey reveals rheumatologists have concerns about biosimilars approval process

The Coalition of State Rheumatology Organizations (CSRO), a nationwide group of state and regional professional rheumatology societies, today released the findings of a national survey of rheumatologists that explored perceptions of biosimilars and the potential impact of these new drugs on patients. [More]
ImmunArray to launch SLE-key Rule Out test for lupus in select U.S. markets

ImmunArray to launch SLE-key Rule Out test for lupus in select U.S. markets

At the premier European forum on rheumatologic disorders, ImmunArray, maker of a breakthrough technology that provides unprecedented levels of accuracy in ruling out the presence of lupus through a simple blood test, announced today that it is launching its new SLE-key™ Rule Out test in selected U.S. markets on July 1, 2015. [More]
Orofacial pain specialists at Case Western Reserve University treat complex health issues

Orofacial pain specialists at Case Western Reserve University treat complex health issues

Andres Pinto, an orofacial pain and oral medicine specialist at Case Western Reserve University School of Dental Medicine, often feels like the doctor in the television series House, who solves medical mysteries each week. [More]
Researcher shares study results of periodontitis and RA at IADR General Session

Researcher shares study results of periodontitis and RA at IADR General Session

Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Sheila Arvikar, Massachusetts General Hospital, Boston, USA, will present a study titled "Inflammation in the Mouth and Joints in Rheumatoid Arthritis." [More]
Stress can trigger diabetes, depression and other autoimmune diseases

Stress can trigger diabetes, depression and other autoimmune diseases

Stress is an ability of humans to fight or flee when faced with problems affecting the individual. By changes in the organism, adaptation to various physical conditions is achieved: burns, bruises, bleeding or psychosocial traumas. [More]
ASBM announces results of European physician survey at EuropaBio – ASEBIO Meeting

ASBM announces results of European physician survey at EuropaBio – ASEBIO Meeting

The Alliance for Safe Biologic Medicines presented results from a survey of European physicians at the "1ST EuropaBio – ASEBIO Meeting on Innovation and Biological Therapies" at the Spanish Ministry of Health, Social Services and Equality. [More]
Juvenile Arthritis Campaign launched to raise awareness about arthritis

Juvenile Arthritis Campaign launched to raise awareness about arthritis

Arthritis & Osteoporosis NSW has recently launched the Juvenile Arthritis Campaign aimed at raising much needed awareness and funds for the thousands of children struggling with arthritis throughout NSW. More than 6,000 children live with the condition and there are many more yet to be diagnosed. [More]
Crescendo Bioscience to present new data on Vectra DA at ACR Annual Meeting

Crescendo Bioscience to present new data on Vectra DA at ACR Annual Meeting

Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that new data on Vectra DA will be featured at the 2014 American College of Rheumatology Annual Meeting, Nov. 15-19, 2014, in Boston, Massachusetts. [More]
New biomarker may improve diagnosis of early-stage rheumatoid arthritis

New biomarker may improve diagnosis of early-stage rheumatoid arthritis

A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, according to a new study in The Journal of Rheumatology. [More]
Timely diagnosis and treatment important to combat juvenile arthritis

Timely diagnosis and treatment important to combat juvenile arthritis

Most people associate arthritis with aging, but the fact is, one in 1,000 children is diagnosed with juvenile arthritis. [More]
Experts join together to call for better screening of psoriatic arthritis

Experts join together to call for better screening of psoriatic arthritis

Leading experts have joined together for the first time to call for better screening of psoriatic arthritis to help millions of people worldwide suffering from the condition. [More]
New survey explores impact of chronic fatigue on people with rheumatoid arthritis

New survey explores impact of chronic fatigue on people with rheumatoid arthritis

The National Rheumatoid Arthritis Society in collaboration with 2020health, a leading health social enterprise think tank, today announces the results from Invisible Disease: RA and Chronic Fatigue 2014, a survey of 1,954 people with Rheumatoid Arthritis (RA), to assess the impact of chronic fatigue on their capability for work, emotional and mental health as well as the overall experience of chronic fatigue caused by their RA. [More]
Polyarticular juvenile idiopathic arthritis (PJIA): an interview with Dr. Kramer, VP, Immunology and Infectious Diseases Medical Unit, Genentech

Polyarticular juvenile idiopathic arthritis (PJIA): an interview with Dr. Kramer, VP, Immunology and Infectious Diseases Medical Unit, Genentech

Polyarticular Juvenile Idiopathic Arthritis (PJIA) is a type of Juvenile Idiopathic Arthritis (JIA), a group of Rheumatoid Arthritis (RA) diseases that manifests in multiple ways in children. [More]
Fracture liaison service reduces risk of fragility fractures in older adults

Fracture liaison service reduces risk of fragility fractures in older adults

Studies have shown that anyone age 50 or older who suffers a fragility fracture – a bone break sustained in a fall from a standing height or less – is two to five times more likely to experience a second fracture than someone who hasn't had one. The odds that a person who's suffered two such fractures will have a third are even higher. [More]
Antares Pharma reports total revenues of $5.2 million for first quarter 2014

Antares Pharma reports total revenues of $5.2 million for first quarter 2014

Antares Pharma, Inc. today reported operating and financial results for the first quarter ended March 31, 2014. [More]
Experts gather for World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Experts gather for World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Investigators and clinicians from more than 60 countries will gather today in Seville, Spain for the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. [More]
Patients with autoimmune disease have 3.8-fold increased risk of developing epilepsy

Patients with autoimmune disease have 3.8-fold increased risk of developing epilepsy

Patients with an autoimmune disease have a 3.8-fold increased risk of developing epilepsy, according to a new population-level study from Boston Children's Hospital based on health insurance claim data. [More]
CT scans allow rheumatologists to diagnose gout

CT scans allow rheumatologists to diagnose gout

Gout is on the rise among U.S. men and women, and this piercingly painful and most common form of inflammatory arthritis is turning out to be more complicated than had been thought. [More]
Fracture liaison services effective in identifying, treating older adults who suffer fragility fracture

Fracture liaison services effective in identifying, treating older adults who suffer fragility fracture

Studies have shown that anyone age 50 or older who suffers a fragility fracture - a bone break sustained in a fall from a standing height or less - is two to five times more likely to experience a second fracture than someone who hasn't had one. The odds that a person who's suffered two such fractures will have a third are even higher. [More]
Horizon Pharma secures $250 million in acquisition financing from Deerfield Management

Horizon Pharma secures $250 million in acquisition financing from Deerfield Management

Deerfield Management Company announced today that it has provided up to $250 million in acquisition financing to Horizon Pharma, Inc. for the acquisition of Vidara Therapeutics International Ltd. [More]
Advertisement
Advertisement